Total Payments
$15,431
2024 Payments
$1,230
Companies
48
Transactions
717
Medicare Patients
8,170
Medicare Billing
$939,660
Payment Breakdown by Category
Food & Beverage$12,057 (78.1%)
Education$3,190 (20.7%)
Travel$185.42 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,057 | 707 | 78.1% |
| Education | $3,190 | 8 | 20.7% |
| Travel and Lodging | $185.42 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $3,282 | 6 | $0 (2023) |
| GlaxoSmithKline, LLC. | $2,242 | 171 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,289 | 71 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,071 | 57 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $841.25 | 46 | $0 (2024) |
| Mylan Specialty L.P. | $803.99 | 43 | $0 (2024) |
| Grifols USA, LLC | $780.20 | 37 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $535.21 | 24 | $0 (2024) |
| United Therapeutics Corporation | $520.64 | 25 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $350.07 | 29 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,230 | 55 | GlaxoSmithKline, LLC. ($172.99) |
| 2023 | $1,384 | 65 | GlaxoSmithKline, LLC. ($262.67) |
| 2022 | $4,472 | 69 | Intuitive Surgical, Inc. ($3,252) |
| 2021 | $869.16 | 50 | GlaxoSmithKline, LLC. ($208.26) |
| 2020 | $1,674 | 94 | Boehringer Ingelheim Pharmaceuticals, Inc. ($307.64) |
| 2019 | $2,256 | 140 | GlaxoSmithKline, LLC. ($414.23) |
| 2018 | $1,795 | 116 | GlaxoSmithKline, LLC. ($356.16) |
| 2017 | $1,752 | 128 | GlaxoSmithKline, LLC. ($390.89) |
All Payment Transactions
717 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $13.45 | General |
| Category: Narcoplepsy | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Inflammation | ||||||
| 09/23/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/19/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Pulmonology | ||||||
| 09/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $41.85 | General |
| Category: Immunology | ||||||
| 09/05/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Cardiology | ||||||
| 08/21/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Respiratory | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Respiratory | ||||||
| 08/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.66 | General |
| Category: Immunology | ||||||
| 08/14/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: NEUROLOGY | ||||||
| 08/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $32.30 | General |
| Category: Narcoplepsy | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: RESPIRATORY | ||||||
| 07/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: RESPIRATORY | ||||||
| 07/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Respiratory | ||||||
| 07/15/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Inflammation | ||||||
| 06/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: RESPIRATORY | ||||||
| 06/12/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Inflammation | ||||||
| 06/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: RESPIRATORY | ||||||
| 06/03/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Respiratory | ||||||
| 05/30/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/30/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/16/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Cardiology | ||||||
| 05/15/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,562 | 2,020 | $467,496 | $163,958 |
| 2022 | 25 | 1,933 | 2,392 | $571,890 | $197,716 |
| 2021 | 22 | 2,051 | 2,645 | $677,155 | $259,104 |
| 2020 | 26 | 2,624 | 3,501 | $874,418 | $318,883 |
Total Patients
8,170
Total Services
10,558
Medicare Billing
$939,660
Procedure Codes
108
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 550 | 619 | $66,260 | $37,032 | 55.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 82 | 226 | $100,450 | $36,943 | 36.8% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 41 | 41 | $60,680 | $16,849 | 27.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 73 | 179 | $30,995 | $16,175 | 52.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 153 | $24,020 | $12,147 | 50.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 76 | 76 | $22,955 | $10,028 | 43.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 58 | 58 | $17,650 | $7,027 | 39.8% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 87 | 91 | $54,600 | $5,149 | 9.4% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 11 | 11 | $16,720 | $4,793 | 28.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $8,005 | $3,744 | 46.8% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 24 | 24 | $16,080 | $2,249 | 14.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 20 | $4,200 | $1,997 | 47.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 33 | $3,715 | $1,894 | 51.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 46 | 46 | $5,060 | $1,366 | 27.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 46 | 46 | $5,520 | $1,366 | 24.7% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 24 | 25 | $12,500 | $1,300 | 10.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 62 | 63 | $6,615 | $976.74 | 14.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 15 | 15 | $1,500 | $931.50 | 62.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 28 | 35 | $2,800 | $550.44 | 19.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 41 | $2,195 | $391.15 | 17.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $560.00 | $375.31 | 67.0% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 13 | 14 | $2,170 | $330.72 | 15.2% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 14 | 15 | $450.00 | $137.39 | 30.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 14 | 15 | $300.00 | $102.11 | 34.0% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 14 | 15 | $600.00 | $94.05 | 15.7% |
About Dr. Darshak Pandya, DO
Dr. Darshak Pandya, DO is a Sleep Medicine healthcare provider based in Rome, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1124248802.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Darshak Pandya, DO has received a total of $15,431 in payments from pharmaceutical and medical device companies, with $1,230 received in 2024. These payments were reported across 717 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($12,057).
As a Medicare-enrolled provider, Pandya has provided services to 8,170 Medicare beneficiaries, totaling 10,558 services with total Medicare billing of $939,660. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Ad
Practice Information
- Specialty Sleep Medicine
- Other Specialties Pulmonary Disease
- Location Rome, GA
- Active Since 04/26/2007
- Last Updated 04/28/2020
- Taxonomy Code 207RS0012X
- Entity Type Individual
- NPI Number 1124248802
Products in Payments
- ION (Device) $3,000
- OFEV (Drug) $1,016
- TRELEGY ELLIPTA (Drug) $1,008
- Prolastin-C Liquid (Biological) $586.29
- SYMBICORT (Drug) $561.99
- NUCALA (Biological) $488.27
- UPTRAVI (Drug) $473.95
- Yupelri (Drug) $443.34
- Wakix (Drug) $372.23
- ORENITRAM (Drug) $368.82
- DUPIXENT (Biological) $342.13
- ANORO (Drug) $341.59
- Da Vinci Surgical System (Device) $281.99
- OPSUMIT MACITENTAN (Drug) $238.98
- YUPELRI (Drug) $220.06
- ACTHAR (Biological) $217.78
- BREO (Drug) $202.56
- Esbriet (Biological) $201.63
- CINQAIR (Biological) $192.79
- ELIQUIS (Drug) $183.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.